U.S. Markets open in 2 hrs 26 mins

Sarepta Therapeutics, Inc. (SRPT)


NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
33.86+0.83 (+2.51%)
At close: 4:00PM EDT
People also watch
ACADCLVSPTCTJUNOCLDX
Full screen
Previous Close33.03
Open33.25
Bid35.00 x 400
Ask36.85 x 1000
Day's Range32.36 - 34.10
52 Week Range18.29 - 63.73
Volume1,208,156
Avg. Volume1,885,832
Market Cap1.86B
Beta2.12
PE Ratio (TTM)-13.98
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • MarketWatch12 hours ago

    Sarepta Therapeutics names new CEO

    Drugmaker Sarepta Therapeutics Inc. on Wednesday named Douglas Ingram its next chief executive. Ingram, currently the president and CEO at Allergan PLC's Chase Pharmaceutics, will start Sept. 20, Sarepta ...

  • The Wall Street Journal12 hours ago

    [$$] Sarepta Taps Chase Pharmaceuticals Chief as Next CEO

    Biopharmaceutical developer Sarepta Therapeutics Inc. named a company outsider as its new chief executive, tapping Douglas Ingram to lead the firm.

  • Reuters14 hours ago

    Sarepta appoints former Allergan executive Douglas Ingram as CEO

    Sarepta Therapeutics Inc said on Wednesday it appointed Douglas Ingram as president and chief executive officer. Ingram, who previously held a senior executive position in Allergan Plc, will also be a ...